Quercetin enhances transforming growth factor β1, secretion by human ovarian cancer cells
- 15 April 1994
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 57 (2), 211-215
- https://doi.org/10.1002/ijc.2910570214
Abstract
Our study demonstrates that quercetin (Q)-induced growth-inhibitory activity in ovarian cancer cells may be mediated by modulation of transforming growth factor beta 1 (TGF beta 1) production. We used the OVCA 433 cell line which is very sensitive to the anti-proliferative effect of Q and expresses high-affinity, low-capacity TGF beta 1 receptors. Conditioned medium (CM) from Q-treated cells is able to displace 125I-TGF beta 1 from binding to its receptor; moreover Q (10 microM) increases TGF beta 1 activity in CM in a time-dependent fashion starting after 4 hr and reaching a maximum by 24 hr of Q treatment. Q-induced growth inhibition is reversed by a neutralizing anti-TGF beta 1 MAb both in OVCA 433 and in a clonogenic assay of cells from a primary ovarian tumor. Q-induced increase of TGF beta 1 activity in CM is specific since other anti-proliferative compounds, such as Dexamethasone, which is as active on the cell cycle as Q, had no effect on TGF beta 1 secretion. Northern-blot analysis of TGF beta 1 mRNA levels at various times of Q (10 microM) exposure revealed that there was no increase, suggesting that regulation of TGF beta 1 occurs at posttranscriptional levels.Keywords
This publication has 19 references indexed in Scilit:
- Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II)Gynecologic Oncology, 1992
- Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cellsMolecular and Cellular Endocrinology, 1992
- Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growthAnti-Cancer Drugs, 1990
- Effects of Retinoic Acid on TGF? Receptor Expression in HL-60 CellsAnnals of the New York Academy of Sciences, 1990
- Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetinInternational Journal of Cancer, 1990
- Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell linesJournal of Cellular Physiology, 1989
- Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibitionJournal of Steroid Biochemistry, 1988
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949